112632 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage; Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
METHODS FOR ANALYZING VIRAL NUCLEIC ACID
#2COMPOSITIONS AND METHODS FOR AMPLIFYING, DETECTING OR QUANTIFYING HUMAN CYTOMEGALOVIRUS
#3METHODS AND SYSTEMS FOR TUMOR DETECTION
#4HSV VECTORS
#5PROBE DESIGN FOR DETECTION OF ONCOGENIC VIRUSES
#6Compositions and Methods for Detecting Nucleic Acids of Epstein-Barr Virus
#7ENHANCEMENT OF CANCER SCREENING USING CELL-FREE VIRAL NUCLEIC ACIDS
#8USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE RISK OF COMPLICATIONS IN A PATIENT ADMITTED TO A HEALTHCARE FACILITY
#9ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION
#10TARGETED MASSIVELY PARALLEL SEQUENCING FOR SCREENING OF GENETIC HEARING LOSS AND CONGENITAL CYTOMEGALOVIRUS-ASSOCIATED HEARING LOSS
#11MULTIPLE AMPLIFICATION CYCLE DETECTION
#12Pathogen Detection From Urine Analyte in All Gender Patients
#13METHOD FOR INHIBITING ADVENTITIOUS VIRAL INFECTION
#14SCREENING PLATFORMS
#15CELL-FREE NUCLEIC ACIDS FOR THE ANALYSIS OF THE HUMAN MICROBIOME AND COMPONENTS THEREOF
#16ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE IN HUMAN SAMPLES
#17ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE IN ANIMAL SAMPLES
#18GAMMA HERPESVIRUS CIRCULAR RNA
#19RNA GUIDED ERADICATION OF VARICELLA ZOSTER VIRUS
#20METHOD FOR THE DETECTION AND QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS BY MEANS OF VIRION RNAS
#21METHODS AND SYSTEMS FOR TUMOR DETECTION
#22DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING
#23PRIMER AND PROBE SETS FOR PATHOGEN DETECTION OF INFECTION IN TRANSPLANT PATIENT, KIT AND USE THEREOF
#24COMPOSITION FOR DETECTING PATHOGENS, AND KIT AND METHOD THEREFOR
#25A METHOD FOR DETECTING MICROORGANISMS
#26METHOD FOR DIAGNOSING AND STAGING HERPESVIRUS-MEDIATED NEURODEGENERATION
#27METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS
#28METHODS TO QUANTIFY VIRUS FROM WASTEWATER
#29COMPOSITIONS AND METHODS FOR AMPLIFYING, DETECTING OR QUANTIFYING HUMAN CYTOMEGALOVIRUS
#30COMPOSITIONS AND METHODS FOR AMPLIFYING OR DETECTING VARICELLA-ZOSTER VIRUS
#31METHOD AND A KIT FOR DETECTING PATHOGENS
#32Compositions and methods for detecting nucleic acids of Epstein-Barr virus
#33METHODS, KITS, AND PRODUCTS FOR DETECTION OF CYTOMEGALOVIRUS INFECTION
#34Cell-free nucleic acids for the analysis of the human microbiome and components thereof
#35Cell-free nucleic acids for the analysis of the human microbiome associated with respiratory infection
#36Cell-free nucleic acids for the analysis of the human microbiome and components thereof
#37Multiple amplification cycle detection
#38Methods for detecting antiviral-drug resistant virus
#39Gamma herpesvirus circular RNA
#40Semiconductor structure and manufacturing method thereof
#41Nanowires/Microscale Pyramids (NWs/MPs) Complex Structure, Method for manufacturing the Same and Its Applications to Isolation of Circulating tumor cells (CTCs) and Detection of Epstein-Barr virus (EBV) DNA
#42METHODS AND MATERIALS FOR DETECTING VIRAL OR MICROBIAL INFECTIONS
#43METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCE USING CLEAVED COMPLEMENTARY TAG FRAGMENT AND A COMPOSITION THEREFOR
#44Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
#45Method for the simultaneous detection and quantification of Epstein-Barr Virus, Cytomegalovirus, Human Herpesvirus 6, Human Herpesvirus 7 and Kaposi's Sarcoma Virus using a multiplex, real-time polymerase chain reaction
#46Kits and methods for assessing a condition or a risk of developing a condition, and related methods of treatment
#47Comprehensive microbial panel for molecular diagnosis of eye infections
#48METHOD FOR DETECTING MICROORGANISMS
#49Enhancement of cancer screening using cell-free viral nucleic acids
#50METHODS OF DETECTING miRNA
#51SYSTEMS and METHODS for DETECTING INFECTIOUS DISEASES
#52Diagnosis and treatment of viral diseases
#53Genetic markers for discrimination and detection of red sea bream iridovirus causing infectious aquatic organism diseases, and method of discriminating and detecting the virus using the same
#54GENETIC MARKERS FOR DISCRIMINATION AND DETECTION OF VIRAL HEMORRHAGIC SEPTICEMIA VIRUS CAUSING INFECTIOUS AQUATIC ORGANISM DISEASES, AND METHOD OF DISCRIMINATING AND DETECTING THE VIRUS USING THE SAME
#55Compositions, methods and kits to detect herpes simplex virus nucleic acids
#56Genetic markers for discrimination and detection of gray SPH region on Koi herprsvirus causing infectious aquatic organism diseases, and method of discriminating and detecting the virus using the same
#57Genetic markers for discrimination and detection of a virus causing red sea bream iridovirus disease which is an infectious aquatic organism disease, and method of discriminating and detecting the virus using the same
#58Cell-free nucleic acids for the analysis of the human microbiome and components thereof
#59METHODS AND DEVICES FOR NASOPHARYNGEAL CARCINOMA SCREENING
#60Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#61Methods of treating CMV retinitis by T cell therapy
#62SYSTEMS and METHODS for DETECTING INFECTIOUS DISEASES
#63METHOD FOR TREATING EPSTEIN-BARR VIRUS - POSITIVE CANCER WITH IMMUNOTHERAPY
#64Kit for detecting silent sexually transmitted diseases (SSTDS) in a urine sample
#65DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING
#66Kit and method for detecting HSV1 and HSV2
#67METHODS FOR ANALYZING VIRAL NUCLEIC ACID
#68Method for detecting target nucleic acid sequence using cleaved complementary tag fragment and a composition therefor
#69Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#70Method and system for characterization for female reproductive system-related conditions associated with microorganisms
#71Enhancement of cancer screening using cell-free viral nucleic acids
#72Compositions, methods and kits to detect Herpes Simplex virus nucleic acids
#73Methods and materials for detecting viral or microbial infections
#74Compositions, methods and kits to detect herpes simplex virus nucleic acid
#75Method to increase the infectivity of virus particles
#76Multiple amplification cycle detection
#77Compositions and methods for detection of herpes simplex virus 1 and 2
#78Methods and systems for tumor detection
#79Genetic markers for discrimination and detection of bercoiver tk region on koi herpesvirus causing infectious aquatic organism diseases, and method of discriminating and detecting the virus using the same
#80Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#81Diagnosis and treatment of viral diseases
#82METHODS OF DETECTING miRNA
#83Devices comprising bacteriophage PHI6 internal control compositions
#84DUMBBELL-STRUCTURE OLIGONUCLEOTIDE, NUCLEIC ACID AMPLIFICATION PRIMER COMPRISING SAME, AND NUCLEIC ACID AMPLIFICATION METHOD USING SAME
#85Integrated Method for Collection and Maintenance of Detectability of a Plurality of Microbiological Agents in a Single Clinical Sample and for Handling a Plurality of Samples for Reporting a Sum of Diagnostic Results for Each Sample
#86IDENTIFICATION OF CELLULAR ANTIMICROBIAL DRUG TABLETS THROUGH INTERACTOME ANALYSIS
#87Method for treating epstein-barr virus—positive cancer with immunotherapy
#88Method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system
#89Diagnosis and treatment of viral diseases
#90Systems and methods for detecting infectious diseases
#91Methods of treating CMV retinitis by T cell therapy
#92Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#93Method of Receiving and Handling a Plurality of Clinical Samples for Reporting a Sum of Diagnostic Results for Each Sample
#94DIAGNOSTIC USE OF VIRUS-ENCODED MICRO RNA HSV1-MIR-H18 AND HSV2-MIR-H9-5P ON PROSTATE CANCER
#95INTEGRATED METHOD FOR COLLECTION AND MAINTENANCE OF DETECTABILITY OF A PLURALITY OF MICROBIOLOGICAL AGENTS IN A SINGLE CLINICAL SAMPLE AND FOR HANDLING A PLURALITY OF SAMPLES FOR REPORTING A SUM OF DIAGNOSTIC RESULTS FOR EACH SAMPLE
#96Methods and materials for detecting viral or microbial infections
#97Methods and devices for nasopharyngeal carcinoma screening
#98Compositions, methods and kits to detect herpes simplex virus nucleic acid
#99ANALYSIS OF POLYNUCLEOTIDES
#100Targeting of herpes simplex virus to specific receptors
#101EBV PROTEINS AS MARKERS IN METHODS OF DIAGNOSING CHRONIC FATIGUE SYNDROME (CFS)
#102Systems and methods for detecting infectious diseases
#103METHODS FOR ASSESSING FATIGUE LEVEL AND APPLICATIONS THEREOF
#104EPSTEIN BARR VIRUS GENOTIPIC VARIANTS AND USES THEREOF AS RISK PREDICTORS, BIOMARKERS AND THERAPEUTIC TARGETS IN MULTIPLE SCLEROSIS
#105Amplification and Sequencing of Transrenal Nucleic Acids
#106METHODS AND DEVICES FOR CANINE HERPESVIRUS 1 (CHV-1) DETECTION AND PREVENTION
#107Cyprinid herpesvirus II-sensitive brain tissue cell line of and establishing method and use thereof
#108Methods and materials for detecting viral or microbial infections
#109Compositions, methods and kits to detect herpes simplex virus nucleic acids
#110Diagnosis and treatment of viral diseases
#111Amplification and sequencing of transrenal nucleic acids
#112COMPOSITION FOR TREATING EPSTEIN-BARR VIRUS INFECTION, COMPRISING EPSTEIN-BARR VIRUS MICRO RNA INHIBITOR
#113Systems and methods for detecting infectious diseases
#114OPTIMIZED PROBES AND PRIMERS AND METHODS OF USING SAME FOR THE BINDING, DETECTION, DIFFERENTIATION, ISOLATION AND SEQUENCING OF HERPES SIMPLEX VIRUS
#115Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#116Medicament for treating peripheral neuropathies
#117METHODS OF DETECTING miRNA
#118DETECTION OF CYTOMEGALOVIRUS DNA USING AMPLIFICATION FROM BLOOD SAMPLES
#119Reducing immunogenicity of xenogeneic transplant tissues
#120OLIGONUCLEOTIDE PRIMERS, PROBES, KITS AND METHODS FOR DETECTION OF CYTOMEGALOVIRUS
#121Cell-free nucleic acids for the analysis of the human microbiome and components thereof
#122Systems and methods for detecting infectious diseases
#123Systems and methods for detecting infectious diseases
#124PATHOGEN SCREENING
#125APPARATUS, METHODS, AND APPLICATIONS FOR POINT OF CARE MULTIPLEXED DIAGNOSTICS
#126Assay methods for MDV-1
#127Assay methods for MDV-1
#128DIAGNOSIS AND TREATMENT OF VIRAL DISEASES
#129Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the Epstein-Barr virus (EBV)
#130DNA chip for diagnosis of genitourinary infections
#131METHODS FOR DETECTION AND DIFFERENTIATION OF ORIGIN OF VIRAL DNA
#132Method to increase the infectivity of virus particles
#133IDENTIFICATION OF AN ALTERED THERAPEUTIC SUSCEPTIBILITY TO ANTI-HCMV COMPOUNDS AND OF A RESISTANCE AGAINST ANTI-HCMV COMPOUNDS
#134DIAGNOSIS AND TREATMENT OF VIRAL DISEASES
#135Methods and materials for detecting viral or microbial infections
#136Guinea pig cytomegalovirus (CIDMTR strain)
#137OLIGONUCLEOTIDE PRIMERS, PROBES, KITS AND METHODS FOR DETECTION OF CYTOMEGALOVIRUS
#138Compositions and methods for detection of herpes simplex virus 1 and 2
#139Method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system
#140OPTIMIZED PROBES AND PRIMERS AND METHODS OF USING SAME FOR THE BINDING, DETECTION, DIFFERENTIATION, ISOLATION AND SEQUENCING OF HERPES SIMPLEX VIRUS
#141Rapid genotyping analysis and devices thereof
#142DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHODS
#143Materials and method for detecting cytomegalovirus (CMV)
#144DETECTION OF CYTOMEGALOVIRUS DNA USING AMPLIFICATION FROM BLOOD SAMPLES
#145Compositions, methods and kits to detect herpes simplex virus nucleic acids
#146Saliva Polymerase Chain Reaction Assay for Cytomegalovirus Infection
#147Assay methods for MDV-1
#148Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)
#149System for Detection of Occult Murine Cytomegalovirus (MCMV)
#150MATERIALS AND METHODS FOR DETERMINING SUBTELOMERE DNA SEQUENCE
#151Methods and compositions related thereto for detecting and identifying distinct species of nucleic acids from causative agents
#152DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING
#153Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
#154COMPOSITIONS FOR USE IN IDENTIFICATION OF HERPESVIRUSES
#155Methods and materials for detecting viral or microbial infections
#156Method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system
#157RAPID GENOTYPING ANALYSIS FOR HUMAN PAPILLOMAVIRUS AND THE DEVICE THEREOF
#158Composition comprising an oligonucleotide mixture for the detection of contaminations in cell cultures
#159Detection of nucleic acids by target-specific hybrid capture method
#160METHODS FOR ASSESSING FATIGUE LEVEL AND APPLICATIONS THEREOF
#161OPTIMIZED PROBES AND PRIMERS AND METHOD OF USING SAME FOR THE DETECTION OF HERPES SIMPLEX VIRUS
#162Detection of nucleic acids by type-specific hybrid capture method
#163OPTIMIZED PROBES AND PRIMERS AND METHODS OF USING SAME FOR THE DETECTION, SCREENING, QUANTITATION, ISOLATION AND SEQUENCING OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS
#164METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC FATIGUE SYNDROME
#165Articles of manufacture for detection of herpes simplex virus
#166Methods of PCR-Based Detection of "Ultra Short" Nucleic Acid Sequences
#167METHODS AND COMPOSITIONS FOR DETECTING CNS VIRUSES
#168Recombinant infectious laryngotracheitis virus and uses thereof
#169Detection of nucleic acids by type specific hybrid capture method
#170Targeting of herpes simplex virus to specific receptors
#171Methods of detecting cell-free miRNA in urine and blood
#172MULTIPLEXED QUANTITATIVE DETECTION OF PATHOGENS
#173Method for the quantitative detection of nucleic acids
#174Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
#175Sequences and Methods for Detection of Cytomegalovirus
#176Nucleic acid sequences that can be used as primers and probes in the amplification and detection of HSV DNA and method for the amplification and detection of HSV DNA using a transcription based amplification
#177Methods for assessing fatigue level and applications thereof
#178Microarray-mediated diagnosis of herpes virus infection by monitoring host's differential gene expression upon infection
#179Detection of Epstein-Barr virus
#180SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY
#181Method and microarray for detecting herpesviruses
#182Chimeric Herpes Viruses and Uses Thereof
#183Recombinant infectious laryngotracheitis virus and uses thereof
#184Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#185Multiplex PCR assay
#186Methods for detecting and typing herpes simplex virus
#187Multiplexed quantitative detection of pathogens
#188Microarray for pathogen identification
#189Integrated method for collection and maintenance of detectability of a plurality of microbiological agents in a single clinical sample and for handling a plurality of samples for reporting a sum of diagnostic results for each sample
#190Detecting pathogens in companion animals
#191Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#192Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases
#193Detection of human herpesviruses
#194Nucleic acid primer set, nucleic acid probe set and method for detecting respiratory disease virus using the primer set and probe set
#195Compositions and methods for detecting human herpesviruses
#196HSV-1 and HSV-2 primers and probes
#197Kit and method and device for the preparation of kit for detecting human cytomegalovirus (hCMV) nucleic acid in biological samples
#198Compositions and methods modulating variola and vaccinia virus
#199Recombinant infectious laryngotracheitis virus and uses thereof
#200Methods and compositions related thereto for detecting and identifying distinct species of nucleic acids from causative agents
#201Kits for the detection of target sequences
#202Methods for detecting DNA viruses
#203Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#204Articles of manufacture for detection of herpes simplex virus
#205Method of detecting and quantifying cytomegalovirus
#206Expression monitoring for human cytomegalovirus (HCMV) infection
#207Diagnosis and treatment of herpes simplex virus diseases
#208Method for the quantitative detection of nucleic acids
#209Cloning of rhadinovirus genome and methods for its use
#210Compounds and methods for treating and screening viral reactivation
#211Identification of etiology of autism
#212Quantitative epstein barr virus PCR rapid assay
#213Compositions and methods modulating variola and vaccinia virus
#214Methods and compositions for modulating herpesviral replication and transcription activator
#215Compositions and kits for Herpes Simplex Virus type 1 and 2 nucleic acid detection
#216Methods and compositions for treatment and prevention of HSV-2 infections and conditions
#217Methods and compositions for inhibiting herpesviral replication
#218Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
#219Viral marker